Bausch Health calls $1.24 billion 5 7/8% notes due 2023

By Wendy Van Sickle

Columbus, Ohio, Dec. 18 – Bausch Health Cos. Inc. issued a conditional call to redeem $1.24 billion of its outstanding 5 7/8% senior notes due 2023 on Jan. 16.

The redemption is subject to the company issuing at least $2.5 billion of new debt, which the company expects to satisfy with closing of its recent offering of $1.25 billion of notes due Jan. 30, 2028, which priced at par to yield 5%, and $1.25 billion of notes due Jan. 30, 2030, which priced at par to yield 5¼%. Both offerings priced on Tuesday.

Based in Laval, Quebec, Bausch develops, manufactures and markets pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.